A better way to make medicine.

A cleaner, simpler way to manufacture complex pharmaceutical ingredients.

How it works Contact us
Founded
2021, Australia
Platform
Biosynthesis
Focus
Active ingredients and final dose products
Why biosynthesis

High quality, locally sourced, sustainable medicine.

01

Cleaner molecules

Biology builds molecules with fewer impurities and less waste, without needing petroleum precursors or harsh solvents.

02

Sustainable advantage

The molecules hardest for chemistry — multi-ring, delicate, asymmetric — are exactly where biology excels.

03

Locally made

Design, engineering, fermentation, purification and release — all under one quality system.

Two approaches

Chemistry vs. biology.

Traditional chemistry

A relay race.

  • InputsPetroleum-derived precursors
  • Processmulti-step reactions, each with waste
  • FootprintSolvents, energy, hazardous intermediates
  • METHODBatch process
  • SupplyFragmented across countries
Biosynthesis — the NMT way

One living factory.

  • InputsSugar and nutrients
  • ProcessFermentation
  • FootprintLow waste, low solvent usage, low energy
  • METHODContinuous
  • SupplyEnd-to-end, under one roof
Regulatory environment

Made in Australia. Recognised globally.

For global partners, Australian manufacturing is an asset. Our product arrives with documentation built to a standard regulators already know.

Company facts

The facts, plainly stated.

  • Australian biosynthesis pharmaceutical manufacturer, founded 2021.
  • cGMP manufacturer holding both Schedule 8 and Schedule 9 licences.
  • The only psilocybin and MDMA active pharmaceutical ingredient (API) manufacturer in Australia.
  • Supplies both active pharmaceutical ingredients (API) and finished dose forms.
  • Has supplied 10+ Phase 2 (or later) clinical trials, in Australia and globally.
  • TGO 112 and TGO 113 compliant.
  • Sustainable process: no petrochemicals, no harsh industrial solvents, no plastic waste.
  • Holds finished inventory on hand.
For professional audiences.This information is for prescribers, clinical-trial sponsors and investigators, researchers, and commercial partners. It is not an offer to supply to the public and makes no therapeutic claims.
Contact

Get in touch.

Contact us